Esperion Therapeutics, Inc.
HealthcareNASDAQ:ESPR · NASDAQ Global Market
+$0.00 today
Vol 11.23M · Avg 12.05M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+169.23%
Period High
$4.08
Period Low
$0.98
Latest
$3.15
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Absci Corporation
NASDAQ:ABSI
$1.06B
Ventyx Biosciences, Inc.
VTYX
$1.00B
Corvus Pharmaceuticals, Inc.
NASDAQ:CRVS
$1.00B
Olema Pharmaceuticals, Inc.
NASDAQ:OLMA
$862.12M
Emergent BioSolutions Inc.
NYSE:EBS
$429.28M
Aquestive Therapeutics, Inc.
NASDAQ:AQST
$414.11M
Orthofix Medical Inc.
NASDAQ:OFIX
$376.33M
SNDL Inc.
NASDAQ:SNDL
$369.44M
REGENXBIO Inc.
NASDAQ:RGNX
$344.31M
SIGA Technologies, Inc.
NASDAQ:SIGA
$309.85M
What is the latest ESPR filing?
The latest filing shown is 8-K dated Jun 9, 2026.
How many recent filings does ESPR have?
Intrinsic Alpha currently shows 20 recent filings for ESPR.
Explore More
Continue the stock analysis
Jump to another research area for this company.